MyProstateScore 2.0 is a personalized, comprehensive, data-driven prostate cancer screening solution designed to predict the presence of clinically significant prostate cancer (Grade Group ≥2 or Gleason score ≥7). The algorithm is specifically optimized for unrivaled accuracy for both previously negative biopsy and biopsy naïve patients.
| Website | https://www.lynxdx.com/ |
| Employees | 87 (59 on RocketReach) |
| Founded | 2015 |
| Phone | +1 614-777-1000 |
| Technologies |
JavaScript
,
HTML
,
Twitter
+12 more
(view full list)
|
| Industry | Biotechnology Research, Diagnostic Equipment |
| Keywords | Prostate Health, Prostate Cancer Screening, Men's Health, Early Cancer Detection, Personalized Medicine, Cancer Risk Assessment, Data Driven Diagnostics, Precision Oncology, Cancer Diagnostics, Digital Health, Predictive Analytics, Clinical Decision Support, Healthcare Technology, Medical Diagnostics, Medical Technology |
| Competitors | Natera, Guardant Health, GRAIL, Myriad Genetics, Foundation Medicine, Invitae, Fulgent Genetics, 23andMe, PathAI, Color +39 more (view full list) |
Looking for a particular LynxDx employee's phone or email?
Steven Riggs is the President of LynxDx.
59 people are employed at LynxDx.